Safety Profile of Extended Release Formulation of Nimesulide in Asian Indian Population: A Prescription Event Monitoring Programme

Drug Safety - Tập 31 - Trang 885-885 - 2013
M. Sharma1,2, A. Chatterjee1, S. K. Gupta3, V. B. Gupta4
1Panacea Biotec limited, New Delhi, India
2Research Scholar B.R. Nahata College of Pharmacy (A SIRO recognised by Ministry of Science and Technology, Govt of India), Mandsaur, India
3Chief Pharmacovigilance Coordinator and Dean, Institute of Clinical Research India, India
4B.R. Nahata College of Pharmacy (A SIRO recognised by Ministry of Science and Technology, Govt of India), Mandsaur, India

Tài liệu tham khảo

Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rheumatology 1999; 38(suppl.1):4–10 Boelsterli UA. Nimesulide and hepatic adverse effects: roles of reactive metabolites and host factors. Int J Clin Pract Suppl 2002; 128:30–6 Conforti A, Leone R, Moretti Ugo, et al. Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide: Results of Spontaneous Reporting from a Northern Italian Area. Drug Safety 2001; 24(14):1081–90 Summary of Product Characteristics: — Nimesulide 100mg Tablet, http://www.emea.eu.int/pdfs/human/referral/nimesulide/308603en.pdf.CPMP/3086/03-REV.1EMEA 2004. Rabasseda X. Safety profile of Nimesulide: ten years of clinical experience. Drugs of Today Vol.33 Suppl.I, 1997
Thông tin
Thông tin xuất bản

Drug Safety

Tập 31

885-885

Thông tin tác giả